Related Articles
Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy
Bax expression as a prognostic marker of postoperative chemoradiotherapy for patients with esophageal cancer
Mesenchymal phenotype after chemotherapy is associated with chemoresistance and poor clinical outcome in esophageal cancer
Protein and gene expression of tumor-associated antigen RCAS1 in esophageal squamous cell carcinoma
CEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma